Supplementary Table 2 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Christopher A. Lucchesi,Jin Zhang,Buyong Ma,Ruth Nussinov,Xinbin Chen

DOI: https://doi.org/10.1158/0008-5472.22428417

2023-01-01

Abstract:List of all the peptide sequences used in the study.

What problem does this paper attempt to address?

Supplementary Table 1 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Christopher A. Lucchesi,Jin Zhang,Buyong Ma,Ruth Nussinov,Xinbin Chen

DOI: https://doi.org/10.1158/0008-5472.22428423.v1

2023-01-01

Abstract:List of all the primers used in the study
Data from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Christopher A. Lucchesi,Jin Zhang,Buyong Ma,Ruth Nussinov,Xinbin Chen

DOI: https://doi.org/10.1158/0008-5472.c.6513018.v1

2023-01-01

Abstract:AbstractRNA-binding motif 38 (RBM38) is a member of a protein family with a highly conserved RNA-binding motif and has been shown to regulate mRNA processing, stability, and translation. Survivin is an essential modulator of apoptotic and nonapoptotic cell death as well as a stress responder. Survivin mRNA is the fourth most frequently overexpressed transcript in the human cancer transcriptome, and its aberrant expression is associated with chemo-/radioresistance and poor prognosis. In this study, we examined whether survivin expression is regulated by RBM38. RBM38 bound to survivin 3′-untranslated region and suppressed miRNA let-7b from binding to and degrading survivin mRNA, leading to increased survivin expression. RBM38 interacted with argonaute-2 (AGO2) and facilitated miR-203a–mediated degradation of survivin mRNA, leading to decreased survivin expression. Due to the abundance of let-7b over miR-203a, RBM38 ultimately increased survivin expression in HCT116 and MCF7 cells. In addition, Ser-195 in RBM38 interacted with Glu-73/-76 in AGO2, and Pep8, an eight-amino acid peptide spanning the region of Ser-195 in RBM38, blocked the RBM38–AGO2 interaction and inhibited miR-203a–mediated mRNA degradation, leading to enhanced survivin expression. Furthermore, Pep8 cooperated with YM155, an inhibitor of survivin, to suppress tumor spheroid growth and viability. Pep8 sensitized tumor cells to YM155-induced DNA damage in an RBM38-dependent manner. Together, our data indicate that RBM38 is a dual regulator of survivin and that Pep8/YM155 may be therapeutically explored for tumor suppression.Significance:These findings show that RBM38 exerts opposing effects on survivin expression via two miRNAs, and disruption of the RBM38–AGO2 complex by an eight-amino acid peptide sensitizes tumor spheroids to survivin inhibitor YM155.
Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Ling-Min Kong,Cheng-Gong Liao,Yang Zhang,Jing Xu,Yu Li,Wan Huang,Yi Zhang,Huijie Bian,Zhi-Nan Chen

DOI: https://doi.org/10.1158/0008-5472.22402862

2023-01-01

Abstract:PDF file - 75K, Oligonucleotide sequence of PCR primers and siRNA fragments.
Supplementary Tables 1-8 from Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395992

2023-01-01

Abstract:PDF file - 226K, TABLE S1: List of miRNAs on human chromosome 3p and the changes of their genome copies determined by genomic real-time PCR; TABLE S2: Clinical significance of the expression of miR-128 in breast cancer patients; TABLE S3: Invariable analysis of clinical outcome according to the expression of miR-128 in breast cancer patients (85 cases); TABLE S4: List of mRNAs predicted to be targeted by miR-128 by all the three programs: MiRanda, Pictar and TargetScan; TABLE S5: qRT-PCR analysis of the effect of forced expression of miR-128 in MDA-MB-231 cells or depleted expression of miR-128 in MCF-10A cells on mRNA levels of several key genes functionally involved in oncogenicity and neoplastic progression; TABLE S6: Sequences of the oligonucleotides for miRNAs, siRNAs, construct-making and ChIP assays; TABLE S7: Sequence of the oligonucleotides for real-time PCR experiments; TABLE S8: List of proteins tested by antibodies and characteristics of the corresponding antibodies used
Supplementary Figure Legend, Tables 1 - 2 from miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a

Bo Guo,Liying Liu,Jiayi Yao,Ruili Ma,Dongmin Chang,Zongfang Li,Tusheng Song,Chen Huang

DOI: https://doi.org/10.1158/1541-7786.22510842

2023-01-01

Abstract:PDF file - 36K, Table S1. Primers for PCR of miRNAs and mRNA. Table S2. Sequence information.
Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

PengXu Qian,Arindam Banerjee,Zheng-Sheng Wu,Xiao Zhang,Hong Wang,Vijay Pandey,Wei-Jie Zhang,Xue-Fei Lv,Sheng Tan,Peter E. Lobie,Tao Zhu

DOI: https://doi.org/10.1158/0008-5472.22395995

2023-01-01

Abstract:PDF file - 190K, Includes patient and specimen data, reagent information, miRNA and siRNA transfection, and statistical analysis. Also includes supplementary references
Supplementary Tables (S1-S2) from Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer Via Activation of Mir-126-5p/β-catenin/cbp Signaling

Geyan Wu,Lixue Cao,Jun Zhu,Zhanyao Tan,Miaoling Tang,Ziwen Li,Yameng Hu,Ruyuan Yu,Shuxia Zhang,Libing Song,Jun Li

DOI: https://doi.org/10.1158/1078-0432.22467648

2023-01-01

Abstract:Supplementary Tables to support primary figures.
Supplementary Table 1 from Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem–like Cell Traits in Breast Cancer

Man-Li Luo,Chang Gong,Chun-Hau Chen,Daniel Y. Lee,Hai Hu,Pengyu Huang,Yandan Yao,Wenjun Guo,Ferenc Reinhardt,Gerburg Wulf,Judy Lieberman,Xiao Zhen Zhou,Erwei Song,Kun Ping Lu

DOI: https://doi.org/10.1158/0008-5472.22398477

2023-01-01

Abstract:PDF file - 35KB, Patient Information for Isolation of Lin-CD24-CD44+ Cells from Human Breast Cancer.
Supplementary Tables from miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Ting-Ting Yan,Lin-Lin Ren,Chao-Qin Shen,Zhen-Hua Wang,Ya-Nan Yu,Qian Liang,Jia-Yin Tang,Ying-Xuan Chen,Dan-Feng Sun,Witold Zgodzinski,Marek Majewski,Piotr Radwan,Ilona Kryczek,Ming Zhong,Jinxian Chen,Qiang Liu,Weiping Zou,Hao-Yan Chen,Jie Hong,Jing-Yuan Fang

DOI: https://doi.org/10.1158/0008-5472.22417232.v1

2023-01-01

Abstract:This file contains supplementary tables 1-7 and the main information was described as follows. Table S1. All primers for real time PCR assay. Table S2. Differentially expressed genes between mesenchymal subtype and other non stem-like. Table S3. microRNA in stem-like/EMT CRC patients. Table S4. Full list of the predicted targets for the four key miRNAs. Table S5. Clinical information of 90 cases CRC patients (Renji cohort 1). Table S6. Clinical information of 100 cases CRC patients (Renji cohort 2). Table S7. Clinical information of 128 cases CRC patients (European cohort).
Supplementary Table 1 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jianzhong Cao,Yongmei Song,Nan Bi,Jie Shen,Wenyang Liu,Jing Fan,Guogui Sun,Tong Tong,Jie He,Yuankai Shi,Xun Zhang,Ning Lu,Yinghua He,Hongyu Zhang,Kelong Ma,Xiaoying Luo,Lei Lv,Hui Deng,Jing Cheng,Jingde Zhu,Luhua Wang,Qimin Zhan

DOI: https://doi.org/10.1158/0008-5472.22397204

2023-01-01

Abstract:PDF file - 53K, The sequences for the four plasmids.
Supplementary Table 3 from AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir Mir-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression

Zhendong Shi,Junxia Zhang,Xiaomin Qian,Lei Han,Kailiang Zhang,Luyue Chen,Jilong Liu,Yu Ren,Ming Yang,Anling Zhang,Peiyu Pu,Chunsheng Kang

DOI: https://doi.org/10.1158/0008-5472.22396694

2023-01-01

Abstract:XLSX file - 596K, The differential expression genes between AC1MMYR2 and DMSO 6-hour treatment were determined after RNA-Seq assay.
Supplementary Table S4. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Si Min Zheng,Yu Chen Feng,Qin Zhu,Ruo Qi Li,Qian Qian Yan,Liu Teng,Yi Meng Yue,Man Man Han,Kaihong Ye,Sheng Nan Zhang,Teng Fei Qi,Cai Xia Tang,Xiao Hong Zhao,Yuan Yuan Zhang,Liang Xu,Ran Xu,Jun Xing,Mark Baker,Tao Liu,Rick F. Thorne,Lei Jin,Thomas Preiss,Xu Dong Zhang,Shundong Cang,Jin Nan Gao

DOI: https://doi.org/10.1158/0008-5472.25735719.v1

2024-01-01

Abstract:List of siRNAs/shRNAs.
Supplementary Table 2 from A Regulatory Loop Involving Mir-22, Sp1, and C-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Ling-Min Kong,Cheng-Gong Liao,Yang Zhang,Jing Xu,Yu Li,Wan Huang,Yi Zhang,Huijie Bian,Zhi-Nan Chen

DOI: https://doi.org/10.1158/0008-5472.22402859

2023-01-01

Abstract:PDF file - 96K, Clinicopathologic characteristics of miR-22 expression in breast cancer patients.
Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229824

2023-01-01

Abstract:Supplementary Table S12. MREs between mRNAs and miRNAs in the survival-related ceRNA network.
Supplementary Table 1 from miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

Jian-Jun Zhao,Jianhong Lin,Di Zhu,Xujun Wang,Daniel Brooks,Ming Chen,Zhang-Bo Chu,Kohichi Takada,Bryan Ciccarelli,Samir Admin,Jianguo Tao,Yu-Tzu Tai,Steven Treon,Geraldine Pinkus,Winston Patrick Kuo,Teru Hideshima,Mary Bouxsein,Nikhil Munshi,Kenneth Anderson,Ruben Carrasco

DOI: https://doi.org/10.1158/0008-5472.22402611

2023-01-01

Abstract:PDF file - 179KB, Sequence of oligonucleotides used in this study.
Supplementary Table S11 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Dongliang Leng,Ziyi Yang,Heng Sun,Chengcheng Song,Chen Huang,Ka U. Ip,Guokai Chen,Chu-Xia Deng,Xiaohua Douglas Zhang,Qi Zhao

DOI: https://doi.org/10.1158/1078-0432.24229827.v1

2023-01-01

Abstract:Supplementary Table S11. MREs between lncRNAs and miRNAs in the survival-related ceRNA network.
Supplementary Table 4 from AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression

Zhendong Shi,Junxia Zhang,Xiaomin Qian,Lei Han,Kailiang Zhang,Luyue Chen,Jilong Liu,Yu Ren,Ming Yang,Anling Zhang,Peiyu Pu,Chunsheng Kang

DOI: https://doi.org/10.1158/0008-5472.22396691.v1

2023-01-01

Abstract:PDF file - 55K, Gene ontology analysis for the biologic processes associated target genes.
Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Yan Wang,Jian Gu,Jack A. Roth,Michelle A.T. Hildebrandt,Scott M. Lippman,Yuanqing Ye,John D. Minna,Xifeng Wu

DOI: https://doi.org/10.1158/0008-5472.22396955

2023-01-01

Abstract:PDF file - 97K, Supplementary Table S1 summarized numbers of miRNA binding sites in TGF-beta pathway-related genes; Supplementary Table S2 showed raw Ct values and normalized expression levels of 35 miRNAs for qRT-PCR assays in 383 serum samples from the NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009; Supplementary Table S3 showed differentially expressed serum miRNAs between Stage III and Stage IV groups for NSCLC study population recruited at the University of Texas MD Anderson Cancer Center between 2002 and 2009.
Supplementary Methods, Figure Legends, Tables 1 - 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Junchao Cai,Jueheng Wu,Huizhong Zhang,Lishan Fang,Yongbo Huang,Yi Yang,Xun Zhu,Rong Li,Mengfeng Li

DOI: https://doi.org/10.1158/0008-5472.22397615

2023-01-01

Abstract:PDF file - 182K, Clinicopathologic characteristics of patients enrolled for sample examination and expression of miR-186 in lung cancer, Correlation between the clinical pathologic features and expression of miR-186 levels
Supplementary Table 1 from An In Vivo Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer

Xiaoping Su,Huaming Wang,Wei Ge,Mingjin Yang,Jin Hou,Taoyong Chen,Nan Li,Xuetao Cao

DOI: https://doi.org/10.1158/0008-5472.22405206

2023-01-01

Abstract:Supplementary Table 1. Relative miRIP isolation of miRNAs predicted by TargetScan in HepG2 and PC-3 cells.

Supplementary Table 2 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Supplementary Table 1 from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Data from Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a

Supplementary Table 1 from A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Supplementary Tables 1-8 from Loss of SNAIL Regulated miR-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Figure Legend, Tables 1 - 2 from miR-338-3p Suppresses Gastric Cancer Progression through a PTEN-AKT Axis by Targeting P-REX2a

Supplementary Materials and Methods from Loss of SNAIL Regulated Mir-128-2 on Chromosome 3p22.3 Targets Multiple Stem Cell Factors to Promote Transformation of Mammary Epithelial Cells

Supplementary Tables (S1-S2) from Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer Via Activation of Mir-126-5p/β-catenin/cbp Signaling

Supplementary Table 1 from Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem–like Cell Traits in Breast Cancer

Supplementary Tables from miR-508 Defines the Stem-like/Mesenchymal Subtype in Colorectal Cancer

Supplementary Table 1 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Table 3 from AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir Mir-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression

Supplementary Table S4. from MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer

Supplementary Table 2 from A Regulatory Loop Involving Mir-22, Sp1, and C-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Supplementary Table S12 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic Cerna Network Related to Immune Infiltration in Sarcoma

Supplementary Table 1 from miR-30-5p Functions as a Tumor Suppressor and Novel Therapeutic Tool by Targeting the Oncogenic Wnt/β-Catenin/BCL9 Pathway

Supplementary Table S11 from Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Supplementary Table 4 from AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression

Supplementary Tables 1 - 3 from Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non–Small Cell Lung Cancer

Supplementary Methods, Figure Legends, Tables 1 - 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Supplementary Table 1 from An &lt;i&gt;In Vivo&lt;/i&gt; Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer

Supplementary Table 1 from An <i>In Vivo</i> Method to Identify microRNA Targets Not Predicted by Computation Algorithms: p21 Targeting by miR-92a in Cancer